CombiMatrix (CBMX) Stock Price, News & Analysis

Company Overview

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.

Key Stats

• Today's Range: $6.25 to $6.25
• 50-Day Range: N/A
• 52-Week Range: $2.20 to $8.20
• Volume: N/A
• Average Volume: 119,111 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CBMX Stock Analysis - Frequently Asked Questions

How were CombiMatrix's earnings last quarter?

CombiMatrix Corp (NASDAQ:CBMX) released its quarterly earnings data on Monday, November, 6th. The medical research company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.03. The medical research company earned $4.01 million during the quarter, compared to analyst estimates of $4.19 million.

When did CombiMatrix's stock split?

CombiMatrix's stock reverse split before market open on Monday, February 1st 2016. The 1-15 reverse split was announced on Wednesday, January 27th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 29th 2016. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of CombiMatrix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CombiMatrix investors own include Vermillion (VRML), Charter Communications (CHTR), CorMedix (CRMD), Glu Mobile (GLUU), Microbot Medical (MBOT) and Rigel Pharmaceuticals (RIGL).

Company Calendar

• Last Earnings: 11/06/2017
• Today: 3/12/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:CBMX
• CIK: 1383183
• Web: combimatrix.com
• Phone: +1-949-7530624
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A